Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats
出版年份 2023 全文链接
标题
Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats
作者
关键词
-
出版物
Hepatitis Monthly
Volume 23, Issue 1, Pages -
出版商
Briefland
发表日期
2023-09-02
DOI
10.5812/hepatmon-138237
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gentisic acid protects against diabetic nephropathy in Nicotinamide-Streptozotocin administered male mice by attenuating oxidative stress and inflammation: The role of miR-200a/Keap1/Nrf2 pathway, renin-angiotensin system (RAS) and NF-кB
- (2023) Reza Noei Razliqi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Gentisic acid ameliorates type 2 diabetes induced by Nicotinamide-Streptozotocin in male mice by attenuating pancreatic oxidative stress and inflammation through modulation of Nrf2 and NF-кB pathways
- (2023) Reza Noei Razliqi et al. LIFE SCIENCES
- Depletion of hepatic stellate cells inhibits hepatic steatosis in mice
- (2022) Akihiro Kawahara et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Comparison of the effects of cholesterol, palmitic acid, and glucose on activation of human hepatic stellate cells to induce liver fibrosis
- (2022) Ghorban Mohammadzadeh et al. Journal of Diabetes and Metabolic Disorders
- Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
- (2022) Kiarash Riazi et al. Nutrients
- TGF-β1 contributes to the hepatic inflammation in animal models with nonalcoholic steatohepatitis by Smad3/TLR2 signaling pathway
- (2022) Qian Chen et al. MOLECULAR IMMUNOLOGY
- The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
- (2021) Carmine Izzo et al. Nutrients
- Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
- (2021) Rasoul Akbari et al. BMC Pharmacology & Toxicology
- The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
- (2020) Divya P. Kumar et al. Scientific Reports
- Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
- (2020) Yunfei Luo et al. Immunity Inflammation and Disease
- The role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases
- (2019) Yan Chen et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Quercetin manipulates the expression of genes involved in the reactive oxygen species (ROS) processin chicken heterophils
- (2018) Boondarika NAMBOOPPHA et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies
- (2018) Andreea-Manuela Mirea et al. TRENDS IN MOLECULAR MEDICINE
- Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
- (2018) Yan-Lan Fang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
- (2018) Amedeo Lonardo et al. ACTA DIABETOLOGICA
- TGF‐β: Master regulator of inflammation and fibrosis
- (2018) Alastair G. Stewart et al. RESPIROLOGY
- A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
- (2017) Zhonge Chen et al. Lipids in Health and Disease
- Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
- (2017) Mukul R. Jain et al. LIVER INTERNATIONAL
- Innate Immunity and Inflammation in NAFLD/NASH
- (2016) Marco Arrese et al. DIGESTIVE DISEASES AND SCIENCES
- Molecular Pathogenesis of NASH
- (2016) Alessandra Caligiuri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
- (2015) Ling Chen et al. Oncotarget
- Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology
- (2014) Wen Liang et al. PLoS One
- Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
- (2013) João Marcus Oliveira Andrade et al. NUTRITION
- Cytokines in alcoholic liver disease
- (2012) Leon An et al. ARCHIVES OF TOXICOLOGY
- Role of cytokines and chemokines in non-alcoholic fatty liver disease
- (2012) Vincent Braunersreuther WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search